Some works on early stage radically resected NSCLC have previously associated tumor-infiltrating lymphocytes (TILs) and immune checkpoint expression, such as programmed death ligand 1 (PD-L1) and lymphocyte activation gene 3 (LAG-3), with patient’s prognosis (5–10). Here, LAG3 is linked to neoplasm.